4 results

Clinical utility of genomic signatures in early-stage breast cancer - INAHTA Brief

Health technology assessment - Posted on 11/02/2019

Download document

Add to my selection
Screening for dihydropyrimidine dehydrogenase deficiency to decrease the risk of severe toxicities related to fluoropyrimidines (5-fluorouracil or capecitabine) - INAHTA Brief

Health technology assessment - Posted on 18/12/2018

Download document

Add to my selection
MRI-guided vacuum-assisted breast biopsy (VABB)

Health technology assessment - Posted on 21/12/2011

Download document

Add to my selection
Place of Breast MRI in the pre-treatment locoregional spread assessment of breast cancer

Health technology assessment - Posted on 31/03/2010

Download document

Add to my selection